Ginkgo Bioworks officer proposes $163K share sale
The proposed shares have an aggregate market value of $162,869.87, and the notice says the sale includes shares to cover an award-related tax obligation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ginkgo Bioworks Holdings, Inc. (DNA) officer Che Austin gave notice of a proposed sale of 16,058 Class A shares through Fidelity Brokerage Services LLC, with an aggregate market value of $162,869.87 and an approximate sale date of October 19, 2026. The sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. During the prior three months, Che Austin reported sales of 2,200 shares on August 17, 2026, and 2,200 shares on September 17, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.